Seroatlas · Human Serome Atlas

SLC22A4

Solute carrier family 22 member 4

Also known as: DFNB60, MGC34546, OCTN1, S22A4_HUMAN

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
Q9H015
Gene
SLC22A4
Ensembl
ENSG00000197208
Chromosome
5
Canonical length
551 aa
Protein class
Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins
Subcellular location
Mitochondria

OverviewNCBI Gene

Polyspecific organic cation transporters in the liver, kidney, intestine, and other organs are critical for elimination of many endogenous small organic cations as well as a wide array of drugs and environmental toxins. The encoded protein is an organic cation transporter and plasma integral membrane protein containing eleven putative transmembrane domains as well as a nucleotide-binding site motif. Transport by this protein is at least partially ATP-dependent. [provided by RefSeq, Jul 2008]

Canonical amino-acid sequenceUniProt

551 residues, UniProt reviewed canonical sequence.

>Q9H015|SLC22A4
     1  MRDYDEVIAF LGEWGPFQRL IFFLLSASII PNGFNGMSVV FLAGTPEHRC RVPDAANLSS
    61  AWRNNSVPLR LRDGREVPHS CSRYRLATIA NFSALGLEPG RDVDLGQLEQ ESCLDGWEFS
   121  QDVYLSTVVT EWNLVCEDNW KVPLTTSLFF VGVLLGSFVS GQLSDRFGRK NVLFATMAVQ
   181  TGFSFLQIFS ISWEMFTVLF VIVGMGQISN YVVAFILGTE ILGKSVRIIF STLGVCTFFA
   241  VGYMLLPLFA YFIRDWRMLL LALTVPGVLC VPLWWFIPES PRWLISQRRF REAEDIIQKA
   301  AKMNNIAVPA VIFDSVEELN PLKQQKAFIL DLFRTRNIAI MTIMSLLLWM LTSVGYFALS
   361  LDAPNLHGDA YLNCFLSALI EIPAYITAWL LLRTLPRRYI IAAVLFWGGG VLLFIQLVPV
   421  DYYFLSIGLV MLGKFGITSA FSMLYVFTAE LYPTLVRNMA VGVTSTASRV GSIIAPYFVY
   481  LGAYNRMLPY IVMGSLTVLI GILTLFFPES LGMTLPETLE QMQKVKWFRS GKKTRDSMET
   541  EENPKVLITA F

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against SLC22A4 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Cell surface
Secreted
No
Transmembrane segments
12
Mean surface accessibility (rSASA)
0.26
Highest tissue expression
20 nTPM

Expression across tissuesHPA

Tissue

  • bone marrow: 20 nTPM
  • fallopian tube: 11 nTPM
  • small intestine: 8.6 nTPM
  • skeletal muscle: 6.8 nTPM
  • kidney: 6.6 nTPM
  • spleen: 4.9 nTPM

Single-cell type

  • cardiomyocytes: 440 nCPM
  • epicardial cells: 280 nCPM
  • neutrophils: 265 nCPM
  • respiratory ciliated cells: 201 nCPM
  • myonuclei: 126 nCPM
  • fallopian tube ciliated cells: 87 nCPM

Immune cell

  • neutrophil: 36 nTPM
  • eosinophil: 5.8 nTPM
  • classical monocyte: 5.6 nTPM
  • myeloid DC: 2.8 nTPM
  • intermediate monocyte: 1.3 nTPM
  • total PBMC: 1.2 nTPM

Brain region

  • medulla oblongata: 12 nTPM
  • midbrain: 11 nTPM
  • spinal cord: 11 nTPM
  • hypothalamus: 11 nTPM
  • cerebellum: 11 nTPM
  • pons: 11 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about SLC22A4.

Disease | AllUniProt

Conditions SLC22A4 is implicated in, by any mechanism.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.98
gnomAD pLI
0
gnomAD missense Z
0.85
DepMap mean gene effect
-0.08
DepMap dependency class
none

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of SLC22A4 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads SLC22A4 as an antibody target. Whether an autoantibody or antibody against SLC22A4 could matter depends on whether native SLC22A4 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

SLC22A4 is annotated at the cell surface, where native SLC22A4 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.

Annotation status

The present source text does not explicitly label SLC22A4 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/SLC22A4. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...